Literature DB >> 8428814

Insurance incentives for ambulatory surgery.

M V Pauly1, M H Erder.   

Abstract

This study is an attempt to address both the extent to which surgical procedures on an outpatient basis substitute cost-effectively for inpatient procedures, and whether or not an insurance policy's financial incentives increase the volume of outpatient surgical procedures. In particular, given an insurance product of a given composition: What is the probability that the insured will have surgery? and if a surgery does take place, what is the probability that it will occur in an outpatient setting? Finally, the article assesses the implication of such products on the total cost of care by quantifying the insurance plans along two parameters, the relative user price for outpatient versus inpatient surgery and the absolute price for the inpatient surgery. The results indicate that insurance policies that offer relatively lower out-of-pocket payments for ambulatory surgery do not increase the probability that surgery will be done in the ambulatory setting. However, higher out-of-pocket payments for surgery, regardless of site, do reduce the surgery rate. There are other patient and market characteristics, especially the availability of freestanding surgery firms, that do influence the location of surgery.

Entities:  

Mesh:

Year:  1993        PMID: 8428814      PMCID: PMC1069914     

Source DB:  PubMed          Journal:  Health Serv Res        ISSN: 0017-9124            Impact factor:   3.402


  3 in total

Review 1.  The cost and value of second surgical opinion programs: a critical review of the literature.

Authors:  P A Lindsey; J P Newhouse
Journal:  J Health Polit Policy Law       Date:  1990       Impact factor: 2.265

2.  Substitution of outpatient for inpatient hospital care: a cost analysis.

Authors:  R A Elnicki
Journal:  Inquiry       Date:  1976-09       Impact factor: 1.730

3.  The demand for hospital outpatient services.

Authors:  M Gold
Journal:  Health Serv Res       Date:  1984-08       Impact factor: 3.402

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.